Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
GlobeNewswire
· The Phase 3 study results are being published in PAIN® Journal, which is the leading journal devoted to pain medicine and..